Abbott Laboratories vs. Viridian Therapeutics, Inc. Common Stock
ABT
Abbott Laboratories
$110.78 -2.48%
VS VRDNViridian Therapeutics, Inc. Common Stock
$28.49 -0.21%
Abbott Laboratories and Viridian Therapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| ABT | VRDN | |
|---|---|---|
| Market Cap | $196.75 billion | $3.24 billion |
ABT leads on 1 of 1 size & scale factors.
Dividend
| ABT | VRDN | |
|---|---|---|
| Dividend Yield | 2.27% | — |
ABT and VRDN split the dividend factors evenly.
Risk & Sentiment
| ABT | VRDN | |
|---|---|---|
| Short Interest | 0.57% | 0.13% |
VRDN leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABT overview, ABT financials, VRDN overview, VRDN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.